3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
1. To investigate the dose response of the combination therapy, Telmisartan and
Hydrochlorothiazide for the Japanese patients with Essential Hypertension.
2. To compare this dose response with that in the US study.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Hydrochlorothiazide Telmisartan Telmisartan, hydrochlorothiazide drug combination